Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xeris Pharmaceuticals Inc (NQ: XERS ) 3.220 -0.010 (-0.31%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Xeris Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 Next > Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 October 31, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) October 04, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris to Participate in Upcoming Investor Conferences August 22, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying August 14, 2024 Via Benzinga Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics May 06, 2024 Via ACCESSWIRE Earnings Outlook For Xeris Biopharma Holdings March 05, 2024 Via Benzinga Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying August 13, 2024 Via Benzinga XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 XERS stock results show that Xeris Biopharma Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Xeris Biopharma Reports Second Quarter 2024 Financial Results August 08, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024 July 25, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma Announces CEO Succession Plan July 08, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 03, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024 June 03, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Intraday Session May 30, 2024 Via Benzinga Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121) May 30, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying May 13, 2024 Via Benzinga XERS Stock Earnings: Xeris Biopharma Holdings Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 XERS stock results show that Xeris Biopharma Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events May 09, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Why Are Xeris Biopharma Shares Moving Monday? May 06, 2024 Xeris Biopharma shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement with Beta Bionics. Xeris said it will work with Beta Bionics to develop and... Via Benzinga Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics May 06, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 May 02, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) April 03, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference April 02, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023 March 06, 2024 XERS stock results show that Xeris Biopharma Holdings met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events March 06, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital March 06, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024 February 28, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Earnings Scheduled For March 6, 2024 March 06, 2024 Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. Via Benzinga Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference February 05, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
